Windtree Therapeutics, Inc. (WINT)

Windtree Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.2	1.78	4.32	6.17	22.35	16.93
Cash & Short-Term Investments	0.2	1.78	4.32	6.17	22.35	16.93
Cash Growth	-91.13%	-58.81%	-30.02%	-72.38%	32.00%	-25.02%
Prepaid Expenses	1.2	0.8	1.06	1.21	1.14	1.19
Total Current Assets	7.21	2.57	5.38	7.38	23.49	18.12
Property, Plant & Equipment	0.77	1.16	1.63	2.12	3.39	1.84
Goodwill	-	-	-	3.06	15.68	15.68
Other Intangible Assets	8	24.13	25.25	25.25	32.07	77.09
Other Long-Term Assets	0.01	0.01	0.15	0.15	0.15	0.15
Total Assets	15.98	27.88	32.41	37.95	74.79	112.89

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	1.65	1.88	0.81	0.25	0.69	1.16
Accrued Expenses	2.01	1.71	1.62	1.55	3.41	3.81
Short-Term Debt	2.7	0.33	0.23	0.25	0.29	0.35
Current Portion of Leases	0.54	0.51	0.44	0.4	0.53	0.81
Other Current Liabilities	15	1.29	0.9	-	-	-
Total Current Liabilities	21.9	5.72	4	2.46	4.92	6.13
Long-Term Debt	-	-	15	15	15	17.42
Long-Term Leases	0.24	0.65	1.16	1.62	2.07	0.2
Long-Term Deferred Tax Liabilities	1.64	4.53	5.06	5.06	7.11	16.78
Other Long-Term Liabilities	3.81	6.98	3.8	3.8	3.8	2.8
Total Liabilities	27.59	17.88	29.02	27.94	32.91	43.33

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0.03	-	-	-	-	0.02
Additional Paid-In Capital	880.78	859.66	851.27	837.6	830.26	790.28
Retained Earnings	-889.37	-846.61	-844.82	-824.53	-785.32	-717.69
Treasury Stock	-3.05	-3.05	-3.05	-3.05	-3.05	-3.05
Shareholders' Equity	-11.61	10	3.39	10.01	41.88	69.55
Total Liabilities & Equity	15.98	27.88	32.41	37.95	74.79	112.89

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	3.49	1.49	16.83	17.28	17.89	18.78
Net Cash (Debt)	-3.28	0.29	-12.51	-11.11	4.46	-1.85
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.40	5.42	-	-	-	-
Filing Date Shares Outstanding	33.71	3.56	0.01	-	-	-
Total Common Shares Outstanding	33.63	0.26	-	-	-	-
Working Capital	-14.7	-3.14	1.38	4.92	18.57	11.99
Book Value Per Share	-0.35	38.99	-	-	-	-
Tangible Book Value	-19.61	-14.13	-21.86	-18.3	-5.87	-23.22
Tangible Book Value Per Share	-0.58	-55.13	-	-	-	-
Machinery	-	1.27	1.26	1.27	5.09	4.98
Leasehold Improvements	-	2.66	2.66	2.65	2.65	2.48

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error